News

ODDITY Tech's Upcoming Earnings: What You Need to Know

ODDITY Tech's Upcoming Earnings: What You Need to Know

ODDITY Tech’s Upcoming Earnings Release

ODDITY Tech (NASDAQ: ODD) is gearing up to share its quarterly earnings report soon. Investors are keenly looking forward to the announcement, which is expected to reveal crucial insights into the company's performance and strategies moving forward.

Expectations for Earnings Performance

Analysts project that ODDITY Tech will report an earnings per share (EPS) of $0.31. This figure draws attention, as analysts often focus on EPS as a benchmark to gauge corporate profitability and financial health.

Market Sentiment Ahead of Earnings

With anticipation surrounding ODDITY Tech's report, the market is primed for possible surprises. Investors hope to see the company exceed expectations and offer positive guidance for the coming quarter, as guidance often significantly influences stock prices.

Historical Performance Trends

In the most recent quarter, ODDITY Tech’s EPS surpassed expectations by $0.08, but this success came with a downside; the share price fell 22.04% the following day. This reaction serves as a stark reminder that market sentiments can shift dramatically based on earnings reports.

ODDITY Tech’s Recent Share Performance

As of the latest trading session, ODDITY Tech shares were priced at $37.2, reflecting a 7.72% decline over the last year. This decline suggests that shareholders may be approaching the earnings release with caution, particularly considering the broader market trends.

Analyst Ratings and Projections

Gaining a clear understanding of market sentiment is vital for investors. ODDITY Tech currently holds a consensus rating of 'Buy' from analysts, stemming from four independent ratings. The average price target is forecasted at $77.5, hinting at a potential upside of 108.33%, which could signal a recovery phase ahead.

Comparative Analysis with Competitors

When examining ODDITY Tech’s performance against competitors like Interparfums, Coty, and Edgewell Personal Care, there's a varied landscape of analyst ratings. Interparfums enjoys a favorable 'Buy' rating with an aggressive one-year price target of $147.0, indicating a staggering upside potential. In contrast, Coty has garnered a 'Neutral' rating with an average price target of $4.84, suggesting potential challenges. Edgewell Personal Care received an 'Outperform' rating, yet with a cautious price target of $22.5.

Peer Comparison Insights

Analyzing the key financial metrics of ODDITY Tech relative to its peers underscores its competitive positioning in the industry. The peer analysis highlights that:

  • ODDITY Tech remains the leader in revenue growth, recording 25.09% growth.
  • In terms of gross profit margins, ODDITY Tech also excels, achieving $174.35 million.
  • However, concerns arise from ODDITY Tech’s return on equity, which stands lower than the industry average.

Understanding ODDITY Tech’s Business Model

ODDITY Tech differentiates itself within the tech sector focused on beauty and wellness. It operates a platform that empowers brands and delivers innovative products based on user data. Notable brands under its umbrella include SpoiledChild and IL Makiage, showcasing the company’s commitment to performance-driven products.

Diving into the Financial Metrics

ODDITY Tech's financial profile reveals several critical aspects:

Market Capitalization: The company's market cap indicates a smaller scale compared to its competitors, which may influence growth strategies and investment perceptions.

Revenue & Net Margin: Achieving a remarkable revenue growth of 25.09% in recent months, ODDITY Tech’s growth rate stands out in the consumer staples industry. However, a net margin of 20.44% signals the company’s challenges in sustaining profitability levels.

Financial Management: ODDITY Tech’s return on equity (ROE) of 14.47% reflects its effective use of shareholder funds, showcasing its financial management strength.

Asset Utilization: Moreover, the company has an impressive return on assets (ROA) at 6.04%, indicating efficient asset utilization compared to its industry peers.

Debt Profile: However, ODDITY Tech’s debt-to-equity ratio of 1.72 suggests a reliance on debt, raising questions about financial leverage management.

Frequently Asked Questions

What is the expected EPS for ODDITY Tech?

The anticipated earnings per share (EPS) for ODDITY Tech is $0.31.

When will ODDITY Tech release its earnings report?

The earnings report is expected to be released shortly, marking an important event for investors.

How did ODDITY Tech's share prices perform in the last quarter?

After beating EPS expectations in the previous quarter, shares dropped 22.04% the next day.

What is the current consensus rating for ODDITY Tech?

ODDITY Tech holds a consensus rating of 'Buy' from analysts.

How does ODDITY Tech compare to its competitors?

ODDITY Tech leads in revenue growth and gross profit but has a lower return on equity compared to competitors like Interparfums and Coty.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading

Top 5 Most Recently Viewed Articles

CRMLS Partners with Rayse to Enhance Agent-Client Transparency

Updated Category News Views 108

CRMLS Enhances Agent Value with Rayse Platform California Regional MLS (CRMLS), the leading multiple listing service in the nation, has made a significant move by integrating Rayse, a state-of-the-art agent value platform, into its offerings. This collaboration allows all CRMLS agent users to access Rayse at no cost directly through their MLS dashboard, marking a pivotal...

Continue Reading
UMG & TikTok's New Deal: A Boon for Artists?

Updated Category News Views 8

A New Era for Music Collaboration Universal Music Group and TikTok just cranked up the volume on their alliance, announcing a fresh, multi-year licensing agreement. This ain't just another handshake—it signals a seismic shift in how music gets discovered and consumed globally. Strengthened Bonds and Broadened Horizons Under this new agreement, TikTok will offer its...

Continue Reading
How an Investment in Thermo Fisher Scientific Transforms Wealth

Updated Category News Views 425

Unveiling the Growth of Thermo Fisher Scientific Investing is often seen as a pathway to wealth, and for those who placed their trust in Thermo Fisher Scientific Inc. (NYSE: TMO) two decades ago, the rewards have been substantial. This company, which specializes in scientific instrumentation, reagents, and consumables, has consistently outperformed the market. 20 Years of...

Continue Reading
European Energy A/S Launches Tender Offer for Green Bonds

Updated Category News Views 63

European Energy A/S Announces Its Tender Offer European Energy A/S has officially informed the market about a new opportunity for its bondholders. The company is targeting holders of its existing senior unsecured green bonds due in 2025 and 2026, inviting them to tender their bonds as part of a strategic financing move. Tender Offer Details Under this tender offer, which...

Continue Reading
Building a Rehabilitation Hospital: Encompass and BSA Join Forces

Updated Category News Views 170

Encompass Health and BSA Health System Join Forces Encompass Health Corp. and BSA Health System have embarked on a collaborative journey that aims to enhance rehabilitation services for patients recovering from various health challenges. This partnership marks a significant expansion in the healthcare landscape, focusing on providing dedicated rehabilitation care. A...

Continue Reading